Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Olema Pharmaceuticals, Inc. (Nasdaq: OLMA) will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 5:15 p.m. ET. The presentation will be led by President and CEO Sean P. Bohen, M.D., Ph.D. A live webcast can be accessed on Olema's website and will remain available for 14 days. Olema is a clinical-stage biopharmaceutical company focused on developing targeted therapies for women’s cancers, with its lead candidate, OP-1250, currently in a Phase 1/2 clinical trial for ER-positive breast cancer.

SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), announced today that Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer, will present a corporate overview and update at the 40^th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 5:15 p.m. ET (2:15 p.m. PT).

A live webcast of the presentation may be accessed under the Investors & Media section of Olema’s website (www.olema.com) and will be archived for 14 days. 

About Olema Oncology 
Olema Oncology is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. Olema’s lead product candidate, OP-1250, is an orally available small molecule with combined activity as both a complete estrogen receptor (ER) antagonist (CERAN) and a selective ER degrader (SERD). It is currently being evaluated as a single agent in an ongoing Phase 1/2 clinical trial in patients with recurrent, locally advanced or metastatic ER-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema is headquartered in San Francisco and has operations in Cambridge, Massachusetts.

FAQ

When will Olema Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Olema Pharmaceuticals will present on January 11, 2022, at 5:15 p.m. ET.

Who will be presenting for Olema at the conference?

Sean P. Bohen, M.D., Ph.D., President and CEO of Olema Pharmaceuticals will present.

Where can I watch the Olema Pharmaceuticals conference presentation?

The presentation will be available via live webcast on Olema's website.

What is Olema Pharmaceuticals' lead product candidate?

Olema's lead product candidate is OP-1250, targeting ER-positive breast cancer.

What type of company is Olema Pharmaceuticals?

Olema Pharmaceuticals is a clinical-stage biopharmaceutical company focused on women's cancers.